• Predicting efficacy of antibody drug conjugate (ADC) combined with aPD-1 x aVEGF bispecific Antibody in Platinum resistant Ovarian Cancer patients using the platform Quantitative Systems Pharmacology (QSP) model

Download Poster

    Scroll to Top